Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Dietel

Showing results (101-110 of 286) with videos related to

Pageof 29
Sort By:
The Prostate|September 25, 2004
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomyChuanliang Xu, Monika Jung, Mick Burkhardt, et al.
Genes, Chromosomes & Cancer|January 22, 2019
Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisionsAlbrecht Stenzinger, Jeffrey D Allen, Jörg Maas, et al.
The Prostate|January 13, 2004
CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancerGlen Kristiansen, Christian Pilarsky, Janja Pervan, et al.
Pathology, Research and Practice|May 28, 2013
Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancerSefer Elezkurtaj, Lutz Moser, Jan Budczies, et al.
The Prostate|December 14, 2002
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesionsGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Virchows Archiv : an International Journal of Pathology|January 20, 2007
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcomePaweł Surowiak, Verena Materna, Adam Maciejczyk, et al.
Cancer Science|April 25, 2006
Expression patterns of polo-like kinase 1 in human gastric cancerWilko Weichert, Andrea Ullrich, Mathias Schmidt, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 25, 2006
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival ratesPawel Surowiak, Verena Materna, Malgorzata Drag-Zalesinska, et al.
Der Pathologe|August 24, 2021
Korinna Jöhrens, Gustavo Baretton, Hans-Ulrich Schildhaus, et al.
Human Pathology|March 16, 2012
High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancerAlbrecht Stenzinger, Daniel Wittschieber, Moritz von Winterfeld, et al.
Pageof 29

Showing results (101-110 of 286) with videos related to

Sort By:
Pageof 29
The Prostate|September 25, 2004
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomyChuanliang Xu, Monika Jung, Mick Burkhardt, et al.
Genes, Chromosomes & Cancer|January 22, 2019
Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisionsAlbrecht Stenzinger, Jeffrey D Allen, Jörg Maas, et al.
The Prostate|January 13, 2004
CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancerGlen Kristiansen, Christian Pilarsky, Janja Pervan, et al.
Pathology, Research and Practice|May 28, 2013
Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancerSefer Elezkurtaj, Lutz Moser, Jan Budczies, et al.
The Prostate|December 14, 2002
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesionsGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Virchows Archiv : an International Journal of Pathology|January 20, 2007
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcomePaweł Surowiak, Verena Materna, Adam Maciejczyk, et al.
Cancer Science|April 25, 2006
Expression patterns of polo-like kinase 1 in human gastric cancerWilko Weichert, Andrea Ullrich, Mathias Schmidt, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 25, 2006
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival ratesPawel Surowiak, Verena Materna, Malgorzata Drag-Zalesinska, et al.
Der Pathologe|August 24, 2021
Korinna Jöhrens, Gustavo Baretton, Hans-Ulrich Schildhaus, et al.
Human Pathology|March 16, 2012
High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancerAlbrecht Stenzinger, Daniel Wittschieber, Moritz von Winterfeld, et al.
Pageof 29